Change of Chief Executive Officer
06 févr. 2018 05h00 HE
|
Genetic Technologies Limited
MELBOURNE, Australia, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), advises that the Board and Mr Eutillio Buccilli have today agreed...
Appointment of Chairman
05 févr. 2018 05h00 HE
|
Genetic Technologies Limited
MELBOURNE, Australia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”, “GTG”), is pleased to announce that the Board of Directors has appointed Dr...
Results from 31 January 2018 General Meeting
31 janv. 2018 05h00 HE
|
Genetic Technologies Limited
MELBOURNE, Australia, Jan. 31, 2018 (GLOBE NEWSWIRE) --
Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”) advises that a General Meeting of shareholders that had been...
Resignation of Directors
30 janv. 2018 05h00 HE
|
Genetic Technologies Limited
MELBOURNE, Australia, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), advises that Dr Malcolm R. Brandon and Mr Grahame Leonard, AM have resigned...
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 31 December 2017
29 janv. 2018 05h30 HE
|
Genetic Technologies Limited
HIGHLIGHTS Completed a three month promotional campaign leading up to and throughout October Breast Cancer Awareness Month Ohio State University: patient recruitment for the collaborative clinical...
Genetic Technologies Regains Nasdaq Listing Compliance
09 janv. 2018 05h00 HE
|
Genetic Technologies Limited
MELBOURNE, Australia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (Nasdaq:GENE) (“Company”), is pleased to advise that the Company received a notification letter (the...
Genetic Technologies Provides Update on Strategic Review Initiative
12 déc. 2017 05h00 HE
|
Genetic Technologies Limited
MELBOURNE, Australia, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), a molecular diagnostics company focused on cancer risk assessment, and...
Notice Received Under Section 249D of the Corporations Act
01 déc. 2017 05h00 HE
|
Genetic Technologies Limited
MELBOURNE, Australia, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), advises that on 29 November it received a notice under Section 249D of the...
Genetic Technologies Limited: Quarterly Activities Report and Appendix 4C of the ASX Listing Rules for the quarter ended 30 September 2017
30 oct. 2017 05h00 HE
|
Genetic Technologies Limited
HIGHLIGHTS Launched a three month promotional campaign leading up to and throughout October Breast Cancer Awareness Month BREVAGenplus commercial program to transition to an ecommerce based...
Genetic Technologies Transitions to Online Commercial Platform for BREVAGenplus®
21 sept. 2017 05h30 HE
|
Genetic Technologies Limited
MELBOURNE, Australia, Sept. 21, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), a molecular diagnostics company specialising in cancer genomics, and...